A Review of the Quality of Life after Therapeutic Maneuvers in Patients with Benign Paroxysmal Positional Vertigo

Document Type : Systematic Review

Authors

Department of Otorhinolaryngology Head and Neck surgery , Anadolu Medical Center, Kocaeli 41400, Turkey

Abstract

Introduction:
Benign paroxysmal positional vertigo (BPPV) is a common cause of peripheral vestibular disturbances. Particle repositioning or liberatory maneuvers provide relief of symptoms in the majority of patients. However, studies mainly focus on success. This study aims to review the conditions that may have an impact on residual dizziness or recurrence following therapeutic maneuvers in patients with BPPV.
 
Materials and Methods:
A review of the literature about the analysis of quality of life after therapeutic maneuvers was conducted. Three hundred and seven articles after search in the PubMed database were classified into eight main groups after exclusion of those that are not suitable to predetermined criteria.
 
Results:
Thirty-eight articles for residual dizziness in BPPV, eighty-three articles for the duration of BPPV, forty articles for the type of canal involvement, forty-three articles for the impact of age, one hundred and nine articles for the gender difference, forty-seven articles for co-morbid conditions, one hundred and twenty-four articles for medication and sixty-eight articles for vestibular exercises in BPPV were selected.
 
Conclusion:
VEMP abnormality is a reliable indicator to demonstrate the risk of recurrence. Duration of dizziness has no significant impact on recurrence. But the length of duration is important for residual dizziness. Vestibular rehabilitation or medication alone has no place in treatment but may help to reduce the symptoms in addition to maneuver. Self-perceived evaluation of balance after therapeutic maneuvers is recommended for the selection of those who need rehabilitation or additional medication.

Keywords

References

  1. Whitney SL, Marchetti GF, Morris LO. The usefulness of the dizziness handicap inventory in the screening for benign paroxysmal positional vertigo. Otol Neurotol 2005;26(5):1027-33.
  2. Parham K, Kuchel GA. A geriatric perspective on benign paroxysmal positional vertigo. J Am Geriatr Soc 2016;64:378-85.
  3. Babac S, Djeric D, Petrovic-Lazic M, Arsovic N, Mikic A. Why do treatment failure and recurrences of benign paroxysmal positional vertigo occur? Otol Neurotol 2014;35:1105-10.
  4.  Seok JI, Lee HM, Yoo JH, Lee DK. Residual dizziness after successful repositioning treatment in patients with benign paroxysmal positional vertigo. J Clin Neurol 2008;4(3):107-10.
  5. Morgan MT, Friscia LA, Whitney SL, Furman JM, Sparto PJ. Reliability and validity of the falls efficacy scale-international (FES-I) in individuals with dizziness and imbalance. Otol Neurotol 2013;34(6):1104-8.
  6. Duracinsky M, Mosnier I, Bouccara D, Sterkers O, Chassany O. Literature review of questionnaires assessing vertigo and dizziness, and their impact on patients' quality of life. Value Health 2007; 10(4): 273-84.
  7. Jacobson GP, Newman CW. The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 1990;116(4):424-7.
  8. Fife D, Fitzgerald JE. Do patients with benign paroxysmal positional vertigo receive prompt treatment? Analysis of waiting times and human and financial costs associated with current practice. Int J Audiol 2005;44:50-7.
  9. Beynon GJ, Baguley DM, da Cruz MJ. Recurrence of symptoms after treatment of posterior semicircular canal benign paroxysmal positional vertigo with a particle repositioning maneuver. J Otolaryngol 2000;29:2-6.
  10. Nunez RA, Cass SP, Furman JM. Short and long-term outcomes of otolith repositioning for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2000;122:647-52.
  11. Lee JD, Park MK, Lee BD, Lee TK, Sung KB, Park JY. Abnormality of cervical vestibular-evoked myogenic potentials and ocular vestibular myogenic potentials in patients with recurrent benign paroxysmal positional vertigo. Acta Otolaryngol 2013; 133:150-3.
  12. Xu H, Liang FY, Chen L, Song XC, Tong MC, Thong JF, et al., Evaluation of the utricular and saccular function using oVEMPs and cVEMPs in benign paroxysmal positional vertigo patients. J Otolaryngol Head Neck Surg 2016;45:12. DOI: 10.1186/s40463-016-0125-7.
  13. Bremova T, Bayer O, Agrawal Y, Kremmyda O, Brandt T, Julian T, et al., Ocular VEMPs indicate repositioning of otoconia to the utricle after successful liberatory maneuvers in benign paroxysmal positional vertigo. Acta Otolaryngol 2013; 133:1297-303.
  14. Hoseinabadi R, Pourbakht A, Yazdani N, Kouhi A, Kamali M. The effects of abnormality of cVEMP and oVEMP on rehabilitation outcomes in patients with idiopathic benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol 2016; 273(3): 643-8.
  15. Seo T, Shiraishi K, Kobayashi T, Mutsukazu K, Fujita T, Saito K, et al., Residual dizziness after successful treatment of idiopathic benign paroxysmal positional vertigo originates from persistent utricular dysfunction. Acta Otolaryngol 2017;137(11):1149-52.
  16. Yetiser S, Ince D, Gul M. An analysis of vestibular evoked myogenic potentials in patients with benign paroxysmal positional vertigo. Ann Otol Rhinol Laryngol. 2014;123(10):686-95.
  17. Pollak L, Segal P, Stryjer R, Stern HG. Beliefs and emotional reactions in patients with benign paroxysmal positional vertigo: a longitudinal study. Am J Otolaryngol 2012;33(2):221-5.
  18. Gunes A, Yuzbasıoglu Y. Effects of treatment on anxiety levels among patients with benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol 2019;276(3):711-8.
  19. Di Girolamo S, Paludetti G, Briglia G, Cosenza A, Santarelli R, Di Nardo W. Postural control in benign paroxysmal positional vertigo before and after recovery. Acta Otolaryngol 1998;118:289-93.
  20. Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, Gomez-Fiñana M, Sanchez-Canet I. Impact of treatment on health-related quality of life in patients with posterior canal benign paroxysmal positional vertigo. Otol Neurotol 2013;24:637-41.
  21. Teggi R, Quaglieri S, Gatti O, Benazzo M, Bussi M. Residual dizziness after successful repositioning maneuvers for idiopathic benign paroxysmal positional vertigo. ORL 2013;75:74-81.
  22. Ding L, Lin T, Zhou X, Han J, Xu A. Analysis of related factors of recurrence in horizontal semicircular canal benign paroxysmal positional vertigo; a pilot study. Acta Otolaryngol 2020; 140(1):8-13.
  23. Soto-Varela A, Rossi-Izquierdo M, Martínez-Capoccioni G, Labella-Caballero T, Santos-Pérez S. Benign paroxysmal positional vertigo of the posterior semicircular canal: efficacy of Santiago treatment protocol, long-term follow up and analysis of recurrence. J Laryngol Otol 2012;126(4):363-71.
  24. Levrat E, van Melle G, Monnier P, Maire R. Efficacy of the Semont maneuver in benign paroxysmal positional vertigo. Arch Otolaryngol Head Neck Surg 2003;129(6):629-33.
  25. Stambolieva K, Angov G. Postural stability in patients with different durations of benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol 2006;263:118-22.
  26. Harvey SA, Hain TC, Adamiec LC. Modified liberatory maneuver: an effective treatment for benign paroxysmal positional vertigo. Laryngoscope 1994;104(10):1206-12.
  27. Do YK, Kim J, Park CY, Chung MH, Moon IS, Yang HS. The effect of early canalith repositioning on benign paroxysmal positional vertigo on recurrence. Clin Exp Otorhinolaryngol 2011;4(3): 113-7.
  28. Faralli M, Lapenna R, Giommetti G, Pellegrino C, Ricci G. Residual dizziness after first benign paroxysmal positional vertigo episode: role of otolithic function and a delayed diagnosis. Eur Arch Otorhinolaryngol 2016;273(10):3157-65.
  29. Martens C, Goplen FK, Aasen T, Nordfalk KF, Nordahl SHG. Dizziness handicap and clinical characteristics of posterior and lateral canal benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol 2019;276:2181-9.
  30. Choi SJ, Lee JB, Lim HJ, Park HY, Park K, In SM et al., Clinical features of recurrent or persistent benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2012;147(5):919-24.
  31. Yoon J, Lee JB, Lee HY, Lee BD, Lee CK, Choi SJ. Potential risk factors affecting repeated canalith repositioning procedures in benign paroxysmal positional vertigo. Otol Neurotol 2018;39(2): 206-11.
  32. Macias JD, Lambert KM, Massingale S, Ellensohn A, Fritz JA. Variables affecting treatment in benign paroxysmal positional vertigo. Laryngoscope 2000;110:1921-4.
  33. Sim E, Tan D, Hill KJ. Poor treatment outcomes following repositioning maneuvers in younger and older adultswith benign paroxysmal positional vertigo: A systematic review and meta-analysis. Am Med Dir Assoc 2019;20(2):224.e1-224.e23.
  34. Yamanaka T, Shirota S, Sawai Y, Murai T, Fujita N, Hosoi H. Osteoporosis as a risk factor for the recurrence of benign paroxysmal positional vertigo. Laryngoscope. 2013;123:2813-6.
  35. Nahm H, Han K, Shin JE, Kim JH. Benign paroxysmal positional vertigo in the elderly: a single-center experience. Otol Neurotol 2019; 40: 1359-62.
  36. Martellucci S, Pagliuca G, De Vincentiis M, Greco A, De Virgilio A, Nobili Benedetti FM et al., Features of residual dizziness after canalith repositioning procedures for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2016;154(4):693-701.
  37. Su P, Liu YC, Lin HC. Risk factors for the recurrence of post-semicircular canal benign paroxysmal positional vertigo after canalith repositioning. J Neurol 2016;263(1):45-51.
  38. Luryi AL, Lawrence J, Bojrab DI, LaRouere M, Babu S, John Zappia J et al., Recurrence in benign paroxysmal positional vertigo: a large, single-institution study. Otol Neurotol 2018; 39(5): 622-7.
  39. Kroenke K, Spitzer RL., Gender Differences in the reporting of physical and somatoform symptoms. Psychosom Med 1998;60(2):150-5.
  40. De Stefano A, Dispenza F, Suarez H, Perez-Fernandez N, Manrique-Huarte R, Jae Ho Ban JH et al., A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris Nasus Larynx 2014;41(1):31-36.
  41. Sreenivas V, Sima NH, Philip S. The role of comorbidities in benign paroxysmal positional vertigo. ENT J 2019. Sep 29;145561319878546. DOI: 10.1177/0145561319878546.
  42. Zhu CT, Zhao XQ, Ju Y, Wang Y, Chen MM, Jui Y. Clinical characteristics and risk factors for the recurrence of benign paroxysmal positional vertigo. Front Neurol 2019 Nov 13;10:1190. DOI: 10.3389/fneur.2019.01190.
  43. Yetiser S. Co-existence of Benign Paroxysmal Positional Vertigo and Meniere's Syndrome. J Int Adv Otol. 2017;13(1):65-68.
  44. Yetiser S. Review of the pathology underlying benign paroxysmal positional vertigo. J Int Med Res. 2020 Apr;48(4):300060519892370.
  45. Acar B, Karasen RM, Buran Y. Efficacy of medical therapy in the prevention of residual dizziness after successful repositioning maneuvers for benign paroxysmal positional vertigo. B-ENT 2015; 11(2):117-21.
  46. Guneri EA, Kustutan O. The effects of betahistine in addition to Epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2012; 146: 104-8.
  47. Cohen HS, Kimball KT. Increased independence and decreased vertigo after vestibular rehabilitation. Otolaryngol Head Neck Surg 2003; 128: 60-70.
  48. Hillier S, McDonnell M. Is vestibular rehabilitation effective in improving dizziness and function after unilateral peripheral vestibular hypofunction? An abridged version of a Cochrane review. Eur J Phys Rehabil Med 2016; 52(4):541-56.
  49. Kulcu DG, Yanik B, Boynukalin S, Kurtais Y. Efficacy of a home-based exercise program on benign paroxysmal positional vertigo compared with betahistine. J Otolaryngol Head Neck Surg 2018;37(3):373-9.
  50. Helminski JO, Janssen I, Kotaspoukis D, Kovacs K, Sheldon P, McQueen K, et al., Strategies to prevent recurrence of benign paroxysmal positional vertigo. Arch Otolaryngol Head Neck Surg 2005; 131:344-8.
Iranian Journal of Otorhinolaryngology
Volume 33, Issue 6
November and December 2021
Pages 339-346

Files

Share

How to cite

Statistics